Long-chain fatty acid oxidation defects
Sep. 12, 2024
This is an image preview.
Start a Free Account
to view the full image.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Myo-inositol biosynthesis and catabolism in mammalian tissues
Most tissues can synthesize myo-inositol following phosphorylation of D-glucose to glucose-6-phosphate with subsequent synthesis of myo-inositol-1-phosphate, which then forms free myo-inositol after dephosphorylation. Myo-inositol can be incorporated into the phosphoinositides cycle, further catabolized to D-glucuronate for renal excretion or converted back to glucose-6-phosphate after a series of enzymatic reactions. Myo-inositol can also be converted to D-chiro-inositol by the enzymatic action of an epimerase. (Source: D’Souza SW, Copp AJ, Greene ND, Glazier JD. Maternal inositol status and neural tube defects: a role for the human yolk sac in embryonic inositol delivery? Adv Nutr 2021;12[1]:212-22. Creative Commons Attribution [CC BY 4.0] license, creativecommons.org/licenses/by/4.0.)